Accretive Wealth Partners’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$721K Sell
28,886
-175
-0.6% -$4.4K 0.15% 101
2026
Q2
$734K Sell
29,061
-255
-0.9% -$6.44K 0.18% 106
2026
Q1
$743K Buy
29,316
+6,986
+31% +$178K 0.21% 104
2025
Q4
$568K Buy
+22,330
New +$569K 0.17% 104

Other funds holding IBDT

Accretive Wealth Partners's IBDT Position: Q3 2026 in Review

Accretive Wealth Partners reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 0.6% in Q3 2026, selling an estimated $4.4K and leaving 28,886 shares worth $721K. The position accounts for 0.15% of the portfolio, ranked #101.

Accretive Wealth Partners first reported a position in IBDT in Q4 2025 and has held it in 4 quarters since. The position peaked at $743K in Q1 2026. 368 funds tracked by Wall St. Rank hold IBDT as of Q3 2026.

  • Accretive Wealth Partners held 28,886 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $721K as of Q3 2026.
  • Accretive Wealth Partners sold 175 iShares iBonds Dec 2028 Term Corporate ETF shares in Q3 2026, an estimated $4.4K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.15% of Accretive Wealth Partners's portfolio in Q3 2026, its #101 holding.
  • Accretive Wealth Partners first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q4 2025 and has held it in 4 quarters since.
  • Accretive Wealth Partners's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $743K in Q1 2026.
  • 368 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q3 2026.

Based on Accretive Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.